Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility

被引：0
|
作者：
Ma, G. Z. M.
Stankovich, J.
Kilpatrick, T. J.
Binder, M. D.
Field, J.
机构：
[1] Univ Melbourne, Multiple Sclerosis Div, Florey Neurosci Inst, Melbourne, Vic, Australia
[2] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia
[3] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：702 / 702
页数：1
相关论文
共 50 条
  • [21] The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis
    Hassani, Nasrin
    Salmaninejad, Arash
    Aslani, Saeed
    Kamali-sarvestani, Eskandar
    Vessal, Mahmood
    IMMUNOLOGICAL MEDICINE, 2023, 46 (02) : 69 - 76
  • [22] The evaluation of VEGF and HIF-1α gene polymorphisms and multiple sclerosis susceptibility
    Saravani, Mohsen
    Rokni, Mohsen
    Mehrbani, Mehrzad
    Amirkhosravi, Arian
    Faramarz, Sanaz
    Fatemi, Iman
    Tarzi, Mojdeh Esmaeili
    Nematollahi, Mohammad Hadi
    JOURNAL OF GENE MEDICINE, 2019, 21 (12):
  • [23] The TYK2 gene is associated with susceptibility to multiple sclerosis
    Mero, I. L.
    Lorentzen, A. R.
    Ban, M.
    Smestad, C.
    Celius, E. G.
    Aarseth, J. H.
    Myhr, K. M.
    Link, J.
    Hillert, J.
    Olsson, T.
    Kockum, I.
    Masterman, T.
    Oturai, A.
    Sondergaard, H. B.
    Sellebjerg, F.
    Saarela, J.
    Kemppinen, A.
    Spurkland, A.
    Lie, B. A.
    Harbo, H.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S186 - S186
  • [24] Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase
    Keating, A. K.
    Salzberg, D. B.
    Sather, S.
    Liang, X.
    Nickoloff, S.
    Anwar, A.
    DeRyckere, D.
    Hill, K.
    Joung, D.
    Sawczyn, K. K.
    Park, J.
    Curran-Everett, D.
    McGavran, L.
    Meltesen, L.
    Gore, L.
    Johnson, G. L.
    Graham, D. K.
    ONCOGENE, 2006, 25 (45) : 6092 - 6100
  • [25] Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma
    Wirsik, Naita Maren
    Chen, Mingyi
    He, Liping
    Yasar, Uraz
    Gaukel, Justus
    Quaas, Alexander
    Nienhueser, Henrik
    Leugner, Ella
    Yuan, Shuai
    Schleussner, Nikolai
    Jung, Jin-On
    Pluecker, Jadie Sue
    Schneider, Martin
    Schmidt, Thomas
    CANCER MEDICINE, 2024, 13 (07):
  • [26] Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase
    A K Keating
    D B Salzberg
    S Sather
    X Liang
    S Nickoloff
    A Anwar
    D DeRyckere
    K Hill
    D Joung
    K K Sawczyn
    J Park
    D Curran-Everett
    L McGavran
    L Meltesen
    L Gore
    G L Johnson
    D K Graham
    Oncogene, 2006, 25 : 6092 - 6100
  • [27] Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis
    Woolmore, J. A.
    Stone, M. J.
    Holley, S. L.
    Jenkinson, P. M.
    Ike, A.
    Jones, P. W.
    Fryer, A. A.
    Strange, R. C.
    Stephens, R.
    Langdon, D. W.
    Hawkins, C. P.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (02) : 177 - 182
  • [28] Melanocortin Receptor-1 Gene Polymorphisms and Multiple Sclerosis Outcome
    Abraham, Roby J.
    Strange, Richard C.
    Raveendran, Vythilingam
    Ramachandran, Sud
    Hawkins, Clive P.
    NEUROLOGY, 2009, 72 (11) : A372 - A373
  • [29] The role of glucocorticoid receptor gene polymorphisms in disease progression in multiple sclerosis
    van Winsen, L.
    Hooper-van Veen, T.
    van Rossum, E. F. C.
    Koper, J. W.
    Barkhof, F.
    Polman, C. H.
    Uitdehaag, B. M. J.
    MULTIPLE SCLEROSIS, 2006, 12 : S76 - S76
  • [30] Promotor Polymorphisms in susceptibility and progression to Multiple Sclerosis
    Guler, S.
    Gurkan, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 532 - 532
12345